Publications by authors named "Dirk Theophiel Deleu"
Case Rep Neurol Med
March 2022
Article Synopsis
- Anti-TNF agents, commonly used to treat autoimmune and inflammatory bowel diseases, have been associated with neurological adverse events, including demyelination.
- Three case studies documented patients who developed neurological symptoms, such as dizziness and numbness, after using adalimumab or infliximab, with MRI scans suggesting multiple sclerosis.
- Discontinuing anti-TNF treatment led to symptom resolution in one case, but relapses occurred in others, indicating a potential causal link between these medications and demyelination that needs further investigation.
